Literature DB >> 24019231

Aerobic fitness is associated with lower risk of hospitalization in children with cystic fibrosis.

Margarita Pérez1, Iris F Groeneveld, Elena Santana-Sosa, Carmen Fiuza-Luces, Laura Gonzalez-Saiz, José R Villa-Asensi, Luis M López-Mojares, Margarita Rubio, Alejandro Lucia.   

Abstract

BACKGROUND: Children with cystic fibrosis (CF) often have to be hospitalized because of acute exacerbation of their respiratory symptoms. Given the fact that improved peak oxygen uptake (VO2peak ) is positively associated with lung function and overall health in children with CF, this study examined the association between VO2peak and the need for hospitalization in a cohort of pediatric CF patients.
METHODS: In a 3-year study, 77 CF children with mild-to-moderately severe CF (forced expiratory volume in 1 sec [FEV1 ] ≥ 50%) underwent a maximal exercise test to determine VO2peak . Anthropometric, lung function and muscle strength measurements were also conducted and dates of hospitalization were recorded for the study period. Associations were then determined between the variables recorded and hospitalization by univariate and multivariate Cox proportional hazards regression analyses.
RESULTS: VO2peak was 38.6 ± 6.7 ml kg(-1)  min(-1) for boys and 31.9 ± 6.9 ml kg(-1)  min(-1) for girls. In multivariate analyses, VO2peak was the only variable significantly associated with time to hospitalization (hazard ratio 0.91, P = 0.03).
CONCLUSION: A significant association was detected between greater aerobic fitness, and lower risk of hospitalization. Because hospitalization due to respiratory exacerbation is a powerful prognostic factor, our findings provide further support for the importance of aerobic fitness evaluation in the management of children with mild-to-moderately severe CF.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  children; cystic fibrosis; fitness; hospitalization; peak oxygen uptake

Mesh:

Year:  2013        PMID: 24019231     DOI: 10.1002/ppul.22878

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  16 in total

1.  Rating of Perceived Exertion in Three-Minute Step Test in Children with Cystic Fibrosis.

Authors:  Amanda P Silva; Erika V Araujo; Igor P Machado; Livia F Alves; Marcos F DA Silva Mello; Pedro Henrique DE A Silva; Isabella R Dias; Viviane Soares
Journal:  Int J Exerc Sci       Date:  2021-04-01

2.  Sildenafil improves vascular endothelial function in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Nichole Lee; Matthew A Tucker; Gábor Csányi; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-31       Impact factor: 4.733

3.  Exercise performance and quality of life in children with cystic fibrosis and mildly impaired lung function: relation with antibiotic treatments and hospitalization.

Authors:  Kristof Vandekerckhove; Michiel Keyzer; Jasper Cornette; Ilse Coomans; Filip Pyl; Frans De Baets; Petra Schelstraete; Filomeen Haerynck; Daniel De Wolf; Sabine Van Daele; Jan Boone
Journal:  Eur J Pediatr       Date:  2017-09-30       Impact factor: 3.183

4.  The Effect of Dysglycaemia on Changes in Pulmonary and Aerobic Function in Cystic Fibrosis.

Authors:  Owen W Tomlinson; Anna L E Stoate; Lee Dobson; Craig A Williams
Journal:  Front Physiol       Date:  2022-03-30       Impact factor: 4.566

5.  Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis.

Authors:  Daniela Savi; Marcello Di Paolo; Nicholas Simmonds; Paolo Onorati; Mattia Internullo; Serena Quattrucci; Banya Winston; Pierantonio Laveneziana; Paolo Palange
Journal:  BMC Pulm Med       Date:  2015-05-09       Impact factor: 3.317

6.  Exercise capacity following a percutaneous endoscopic gastrostomy in a young female with cystic fibrosis: a case report.

Authors:  Owen W Tomlinson; Alan R Barker; Patrick J Oades; Craig A Williams
Journal:  Physiol Rep       Date:  2016-08-22

Review 7.  Functional Capacity in Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Camila Wohlgemuth Schaan; Aline Chagastelles Pinto de Macedo; Graciele Sbruzzi; Daniel Umpierre; Beatriz D Schaan; Lucia Campos Pellanda
Journal:  Arq Bras Cardiol       Date:  2017-09-04       Impact factor: 2.000

8.  Long-term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation.

Authors:  M Marcella Burghard; G Gitte Berkers; S Sophie Ghijsen; Fm Francis Hollander-Kraaijeveld; Km Karin de Winter-de Groot; Ck Kors van der Ent; Hgm Harry Heijerman; T Tim Takken; Hj Erik Hulzebos
Journal:  Pediatr Pulmonol       Date:  2020-03-31

9.  Effects of high intensity interval training on exercise capacity in people with cystic fibrosis: study protocol for a randomised controlled trial.

Authors:  Abbey Sawyer; Vinicius Cavalheri; Sue Jenkins; Jamie Wood; Nola Cecins; Bhajan Singh; Kylie Hill
Journal:  BMC Sports Sci Med Rehabil       Date:  2018-11-06

10.  Analysis of oxygen uptake efficiency parameters in young people with cystic fibrosis.

Authors:  Owen W Tomlinson; Alan R Barker; Lucy V Chubbock; Daniel Stevens; Zoe L Saynor; Patrick J Oades; Craig A Williams
Journal:  Eur J Appl Physiol       Date:  2018-07-12       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.